Drugs / YH02
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07697937 | Jun 2026 → May 2028 expected | cancer | Tianjin First Central Hospital | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | YH02 | “The preclinical pharmacological mechanism of YH02 injection is well established.” NCT07697937 ↗ |
| Route | Other | “intratumoral administration of YH02 injection” NCT07697937 ↗ |